机构:[1]MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systematic Biology, School of Life Sciences, Tsinghua University, 100084, Beijing, China.[2]BeiGene (Beijing) Co., Ltd., 100084, Beijing, China.[3]Institute of Chinese Medicine, Guangdong Pharmaceutical University, 510006, Guangzhou, China.[4]Beijing Chao-yang Hospital, Capital Medical University, 100043, Beijing, China.北京朝阳医院
Ministry of Science and Technology of the People’s
Republic of China (grant nos. 2017YFA0505103 and 2020YFC2002705), and the
National Natural Science Foundation of China (grant nos. 21877068 and
20211300114).
第一作者机构:[1]MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systematic Biology, School of Life Sciences, Tsinghua University, 100084, Beijing, China.
通讯作者:
推荐引用方式(GB/T 7714):
Ma Yingying,Yi Meiqi,Wang Weixuan,et al.Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibility[J].CELL DEATH & DISEASE.2022,13(11):doi:10.1038/s41419-022-05383-7.
APA:
Ma Yingying,Yi Meiqi,Wang Weixuan,Liu Xiaohui,Wang Qingtao...&Deng Haiteng.(2022).Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibility.CELL DEATH & DISEASE,13,(11)
MLA:
Ma Yingying,et al."Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibility".CELL DEATH & DISEASE 13..11(2022)